A Systematic Review and Meta-analysis of the Accuracy of Diffusion-weighted MRI in the Detection of Malignant Pulmonary Nodules and Masses

Academic Radiology

Volumn 21, Issue 1, 2014, Pages 21-29

  Li, Bin ^a   Li, Qiong ^a   Chen, Cong ^b   Guan, Yu ^a   Liu, Shiyuan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 100 Hospital of PLA   (China)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Meta analysis; Pulmonary nodules or masses

Indexed keywords

ARTICLE; COCHRANE LIBRARY; DATA BASE; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; EMBASE; HUMAN; LUNG LESION; LUNG NODULE; LUNG TUMOR; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SYSTEMATIC REVIEW;

DIFFUSION-WEIGHTED IMAGING; MAGNETIC RESONANCE IMAGING; META-ANALYSIS; PULMONARY NODULES OR MASSES;

DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE;

EID: 84890185090     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.09.019     Document Type: Article

References (35)

1. Travis W.D., Brambilla E., Riely G.J. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 2013, 31(8):992-1001.
2. Boiselle P.M. Computed tomography screening for lung cancer. JAMA 2013, 309(11):1163-1170.
3. Bomanji J., Almuhaideb A., Zumla A. Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation. Curr Opin Pulm Med 2011, 17(3):197-205.
4. London K., Stege C., Cross S., et al. 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors. Pediatr Radiol 2012, 42(4):418-430.
5. Ozgul M.A., Uysal M.A., Kadakal F., et al. [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer]. Tuberk Toraks 2006, 54(3):229-234. [Article in Turkish].
6. Puderbach M., Kauczor H.U. Can lung MR replace lung CT?. Pediatr Radiol 2008, 38(Suppl 3):S439-S451.
7. Razek A.A., Fathy A., Gawad T.A. Correlation of apparent diffusion coefficient value with prognostic parameters of lung cancer. J Comput Assist Tomogr 2011, 35(2):248-252.
8. D'Ippolito G., Torres L.R., Saito Filho C.F., et al. CT and MRI in monitoring response: state-of-the-art and future developments. Q J Nucl Med Mol Imaging 2011, 55(6):603-619.
9. Koyama T., Tamai K., Togashi K. Current status of body MR imaging: fast MR imaging and diffusion-weighted imaging. Int J Clin Oncol 2006, 11(4):278-285.
10. Wang W., Xu J.Z., Zhang T., et al. Diffusion-weighted magnetic resonance imaging with short T1 inversion recovery-echo planar imaging combined with dual-head coincidence single photon emission computed tomography for diagnosing solitary pulmonary nodule. Chin Med J (Engl) 2010, 123(24):3717-3721.
11. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Res Methodol 2003, 3:25.
12. Zamora J., Abraira V., Muriel A., et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Medical Res Methodol 2006, 6:31.
13. Sinkus R., Van Beers B.E., Vilgrain V., et al. Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. Eur J Cancer 2012, 48(4):425-431.
14. Santos M.K., Elias J., Mauad F.M., et al. Magnetic resonance imaging of the chest: current and new applications, with an emphasis on pulmonology. J Bras Pneumol 2011, 37(2):242-258.
15. Liu H., Liu Y., Yu T., et al. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 2010, 20(4):807-815.
16. Uto T., Takehara Y., Nakamura Y., et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009, 252(1):247-254.
17. Chen A.P., Li H.M., Liu S.Y., et al. Differentiation of malignant and benign pulmonary lesions with diffusion-weighted imaging. Chin Comput Med Imaging 2010, 16(3):206-210.
18. Wang M.J., Zhang W., Zhang N., et al. Diagnostic value of 3.0 T magnetic resonance diffusion-weighted imaging in benign and malignant lung tumors. Acta Academiae Medicinae Jiangxi 2011, 51(11):14-19.
19. Wu L.M., Xu J.R., Hua J., et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?. Magn Reson Imaging 2013, 31(2):235-246.
20. Chen L., Zhang J., Bao J., et al. Meta-analysis of diffusion-weighted MRI inthe differential diagnosis of lung lesions. J Magn Reson Imaging 2013, 37(6):1351-1358.
21. Mori T., Nomori H., Ikeda K., et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 2008, 3(4):358-364.
22. Usuda K., Zhao X.T., Sagawa M., et al. Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 2011, 91(6):1689-1695.
23. Satoh S., Kitazume Y., Ohdama S., et al. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?. AJR Am J Roentgenol 2008, 191(2):464-470.
24. Gümüştaş S., Inan N., Akansel G., et al. Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging. Radiol Oncol 2012, 46(2):106-113.
25. Cronin P., Dwamena B.A., Kelly A.M., et al. Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests. Eur Radiol 2008, 18(9):1840-1856.
26. Tondo F., Saponaro A., Stecco A., et al. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med 2011, 116(5):720-733.
27. Regier M., Schwarz D., Henes F.O., et al. Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 2011, 55(3):266-274.
28. Ohba Y., Nomori H., Mori T., et al. Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla. Asian Cardiovasc Thorac Ann 2011, 19(2):108-114.
29. Koyama H., Ohno Y., Aoyama N., et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010, 20(4):790-800.
30. Tanaka R., Horikoshi H., Nakazato Y., et al. Magnetic resonance imaging inperipheral lung adenocarcinoma: correlation with histopathologic features. J Thorac imaging 2009, 24(1):4-9.
31. Ohba Y., Nomori H., Mori T., et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?. J Thorac Cardiovasc Surg 2009, 138(2):439-445.
32. Wu W.H., Chen J.J., Xu J.R., et al. The preliminary study of MR diffusion weighted imaging with background body signal suppression on pulmonary diseases. Zhonghua Fang She Xue Za Zhi 2008, 42(1):56-59.
33. Cai C.X., Zhao S.S., Lin L.P., et al. The value of MR diffusion weighted imaging with STIR-EPI sequence for differentiating benign from malignant pulmonary nodules. J Pract Med Imaging 2011, 12(6):358-361.
34. Li W.D., Li D., Liu H.D., et al. 3.0T MR diffusion-weighted imaging: evaluating diagnosis potency of pulmonary solid benign lesions and malignant tumors and optimizing b value. Zhongguo Fei Ai Za Zhi 2011, 14(11):853-857.
35. Deng Q.M., Qiu W.J., Zhang P.P., et al. The value on distinguishing pulmonary malignant tumors from benign lesions by diffusion-weighted imaging. Chinese CT and MRR magazine 2012, 10(1):35-37.